IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

605.00

Prev. Close

605.50

Turnover (lac.)

11,594

Day's High

611.90

Day's Low

595.15

52 Week's High

838.00

52 Week's Low

536.60

Book Value

199

Face Value

1

Mkt Cap (Cr.)

35,291

P/E

21.57

EPS

27.91

Divi. Yield

0.42

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd414.7045.4399,512.42763.370.663,020.4995.21
Dr Reddys Laboratories Ltd2,492.5527.6741,408.86548.100.802,497.60766.80
Divis Laboratories Ltd1,507.3029.9939,992.84267.351.061,139.92262.68
Cipla Ltd476.1017.5138,380.42694.000.633,126.21195.83
Piramal Enterprises Ltd1,782.30186.8535,453.82-38.841.46871.981,007.19

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by Aurobindo-Pharma-Ltd

View

- <

Reco. Price

Aug 14,2019 05:43 PM

Target Price

Target Returns:

0.00%

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Aug 19, 2019 04:51 AM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    07 Aug 2019

    Annc. Date

    26 Jul 2019

    AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is s... More

  • Purpose

    Board Meeting

    Exp. Date

    28 May 2019

    Annc. Date

    18 May 2019

    AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is s... More

  • Purpose

    Dividend

    Annc. Date

    07 Feb 2019

    Effective. Date

    15 Feb 2019

    Divi. Type

    Interim 2

    Divi.(%)

    125

    Divi. Amt.

    1.25

    The Board of Directors of the Company at its meeting held today, February 7, 2019, has inter alia, a... More